• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    WuXi STA Opens High-Potency API Plant

    Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility

    Phastar Appoints Chris Schoonmaker as Chief Operations Officer
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    WuXi STA Opens High-Potency API Plant

    Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility

    Shimadzu Scientific Instruments Extends HQ Campus
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Biosynth Carbosynth

    Societal CDMO

    Qosina

    Baxter BioPharma Solutions

    IDT Biologika
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Biosynth Carbosynth

    Societal CDMO

    Qosina

    Baxter BioPharma Solutions

    IDT Biologika
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Biomunex Appoints Dr. Simon Plyte as Chief Scientific Officer

    Plyte has a proven track record in drug discovery and development.

    Biomunex Appoints Dr. Simon Plyte as Chief Scientific Officer
    Dr. Simon Plyte.
    04.25.22
    Biomunex Pharmaceuticals, a biopharmaceutical company that develops immunotherapies through the discovery and development of bi- and multi-specific antibodies in cancer treatment, has appointed Dr. Simon Plyte as chief scientific officer (CSO) and as a member of its scientific advisory board.
     
    Plyte brings a wealth of knowledge and experience, spanning over two decades in R&D at the senior management level, within the pharmaceutical and biotechnology industry. He has a proven track record in drug discovery and development, successfully bringing both New Chemical Entities and New Biological Entities to the clinic in oncology.
     
    This appointment will strengthen and significantly impact Biomunex’s R&D strategy: to use Biomunex’s bi-specific antibody platform, BiXAb, in the redirection of its unique non-conventional T cell subset for the treatment of cancer and to advance the antibody platform to tri-specificity and beyond. Biomunex was one of the national laureates of the ‘New biotherapies and bioproduction tools’ scheme in November 2021 for a project focused on its non-conventional T Cell redirection approach, which received close to $3.5 million in grants from the French government.
     
    “I am thrilled to join Biomunex and bring to the team my expertise in drug discovery and development in both big pharma and biotech; especially in the field of bi- and multi-specific antibodies. Biomunex’s unique proprietary BiXAb technology platform has best-in-class potential for the rapid creation of bi- and multi-specific antibodies from any pair of monoclonal antibodies with no extensive engineering and with excellent manufacturability,” said Plyte. “It has demonstrated both its relevance and potential through several key collaborations, such as those with Sanofi, Onward Therapeutics and the Institut Curie. I am glad to work with the team as we pave the way for safer and more efficacious disruptive immunotherapeutic approaches.”
     
    Dr. Pierre-Emmanuel Gerard, CEO and founder of Biomunex, said, “We are delighted to welcome Dr. Simon Plyte to the team and the scientific advisory board. With his extensive dual expertise in discovery and development in both biotech and pharma, Simon will help bring Biomunex drug candidates forward through preclinical and early clinical development. His invaluable R&D experience and strong managerial skills will further support our ambitions in relation to our current fundraising activities.”
     
    Plyte’s appointment is part of Biomunex’s strategy to strengthen its internal scientific knowledge base. Biomunex recently opened new laboratories in Paris and has established a scientific advisory board focused on non-conventional T Cell redirection.

    Experience

    Plyte has over 20 years hands-on experience in biotech and large pharmaceutical companies and a strong background in discovering and developing innovative new drugs in oncology, in particular in bispecific antibodies. Before joining Biomunex, he held the positions of vice-president, immuno-oncology, at Merus (Utrecht, Netherlands), senior director, immuno-oncology, at Molecular Partners AG (Zurich, Switzerland) and director in Immuno-Oncology and New Biological Entities at Boehringer Ingelheim (Biberach, Germany).
     
    Prior to joining Boehringer Ingelheim, Plyte was focused on the development of new drugs in oncology, both in big pharma (Pharmacia/Pfizer) and small biotech (Congenia, Nerviano Medical Sciences).
     
    Before entering the industry, Plyte was a post-doctoral fellow at the Ludwig Institute for Cancer Research (London, UK) and the Ontario Cancer Institute (Toronto, Canada). He has a PhD in biochemistry and biophysics from the University of Portsmouth, UK. Plyte is the co-author of more than 30 publications and patents.
    Related Searches
    • Drug Development
    • Drug Discovery

    Related Content

      Loading, Please Wait..
      Trending
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Almac Participates In Global Clinical Supply BlockChain Working Group
      • Regulatory Report: Analytical Procedure Development
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Batavia Enters Commercial Manufacturing Business
      Breaking News
      • Takeda to Expand U.S. Footprint
      • Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
      • WuXi STA Opens High-Potency API Plant
      • Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Pharmavite Expands in Ohio with $200 Million Investment
      Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
      Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
      Coatings World

      Latest Breaking News From Coatings World

      Clariant’s Launches Dispersogen Flex 100
      Lincoln Tech Enters Partnership with AkzoNobel
      AkzoNobel Launches International Interzone 945GF
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      ENDRA Life Sciences Issued 27th Patent
      AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
      Simon Johnson Appointed as Senior Business Development VP at MedAcuity
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Takeda to Expand U.S. Footprint
      Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
      WuXi STA Opens High-Potency API Plant
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Latest Updates About Cosmoprof North America
      Meet the Clean Beauty Brand for Dogs
      Paco Rabanne Introduces Elle Fanning as Ambassador for New ‘Fame’ Fragrance
      Happi

      Latest Breaking News From Happi

      Two-Part Skincare Product Patented by Estée Lauder Companies
      American Cleaning Institute Pens Letter to Congress Encouraging Examination of Recyclability Improvements
      The Expert Panel for Fragrance Safety Celebrates 55 Years
      Ink World

      Latest Breaking News From Ink World

      INX Launches INXFlex Contour for Shrink Sleeve Market
      Xerox Announces Unexpected Passing of Vice Chairman and CEO John Visentin
      MNYPIA Golf Outing Set to Tee Off on Aug. 17
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Meyers purchased by third generation of Dillon family
      Epson now shipping ColorWorks C4000 inkjet label printer
      Nobelus launches new films for prime labels
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      What You’re Reading on Nonwovens-Industry.com
      Daio, Livedo Partner to Recycle Diapers
      Suominen Launches Hydraspun Reserve
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      3D Systems and EMS-GRILTECH Enter Strategic Partnership
      AIP Researchers Develop Microfluidic-Based Soft Robotic Prosthetic
      David Sharp Named Global Marketing VP at Catalyst OrthoScience
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Impinj Launches E910 RFID Reader Chip for Next Generation Enterprise IoT
      onsemi Receives Recognition for Sustainability for Third Straight Year
      Xerox Announces the Unexpected Passing of Vice Chairman and CEO John Visentin

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login